Although the upregulation of S100A4 in low-avidity tumors was not statistically significant (p = 0.12), this gene was included in the validation list of genes due to its established role in thyroid cancer and its involvement in tumorigenesis across various other cancer types (Supplementary Fig. 1). This evidence concerns the gene S100A4 and cancer.